|
業務類別
|
-- |
|
業務概覽
|
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301. |
| 公司地址
| Schalienhoevedreef 20 T, Mechelen, BEL, 2800 |
| 電話號碼
| +32 15342900 |
| 傳真號碼
| +32 15342901 |
| 公司網頁
| https://www.lakefrontbio.com |
| 員工數量
| 452 |
| Mr. Aaron L. Cox |
Chief Financial Officer and Executive Vice President |
-- |
26/03/2026 |
| Mr. Fred Blakeslee |
General Counsel and Executive Vice President |
-- |
26/03/2026 |
| Mr. Henry O. Gosebruch |
Director and Chief Executive Officer |
-- |
26/03/2026 |
| Ms. Tania Philipp |
Chief Human Resources Officer |
-- |
26/03/2026 |
|
|
| Mr. Henry O. Gosebruch |
Director and Chief Executive Officer |
26/03/2026 |
| Mr. Devang Bhuva |
Director |
26/03/2026 |
| Mr. Neil Johnston |
Independent Director |
26/03/2026 |
| Dr. Linda Higgins, PhD |
Director |
26/03/2026 |
| Ms. Dawn A. Svoronos |
Independent Director |
26/03/2026 |
| Dr. Jane Veronica Griffiths |
Independent Director |
26/03/2026 |
| Mr. Oleg Nodelman |
Director |
26/03/2026 |
| Mr. Gino Santini |
Chairman of the Board |
26/03/2026 |
|
|
|
|
